# A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

> **NCT00304291** · PHASE4 · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 5 (—)

## Conditions studied

- Neuromyelitis Optica
- Myelitis, Transverse
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System

## Interventions

- **DRUG:** Mitoxantrone

## Key facts

- **NCT ID:** NCT00304291
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 5 (—)
- **Last updated:** 2020-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304291, "A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00304291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*